# Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

> **NCT06674330** · — · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Hematological Malignancies
- Critical Illness

## Interventions

- **OTHER:** concentration of teicoplanin

## Key facts

- **NCT ID:** NCT06674330
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06674330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06674330, "Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06674330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*